Collectively, our results demonstrate that the downregulation of MBNL1 plays an essential role in the development and progression of GBM through the inhibition of glycolysis and proliferation by circNTRK2-dependent regulation of the PAX5 expression via encoding NTRK2-243aa (Fig. 8). This evidence concerns the gene MBNL1 and glioblastoma.